Bank of America’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$683K Sell
249,395
-447,395
-64% -$1.42M ﹤0.01% 4725
2025
Q4
$2.58M Buy
696,790
+392,218
+129% +$1.27M ﹤0.01% 3869
2025
Q3
$807K Sell
304,572
-531,767
-64% -$1.03M ﹤0.01% 5469
2025
Q2
$823K Sell
836,339
-690,924
-45% -$692K ﹤0.01% 5421
2025
Q1
$2.2M Sell
1,527,263
-102,717
-6% -$189K ﹤0.01% 4597
2024
Q4
$3.59M Buy
1,629,980
+506,428
+45% +$1.18M ﹤0.01% 3909
2024
Q3
$1.85M Sell
1,123,552
-39,872
-3% -$80.5K ﹤0.01% 4619
2024
Q2
$2.58M Sell
1,163,424
-3,381,836
-74% -$7.96M ﹤0.01% 4226
2024
Q1
$12.2M Buy
4,545,260
+4,368,724
+2,475% +$10.6M ﹤0.01% 2787
2023
Q4
$528K Buy
176,536
+72,031
+69% +$93.4K ﹤0.01% 5456
2023
Q3
$102K Sell
104,505
-79,616
-43% -$115K ﹤0.01% 6243
2023
Q2
$256K Sell
184,121
-329,078
-64% -$459K ﹤0.01% 5669
2023
Q1
$816K Buy
513,199
+425,704
+487% +$2.2M ﹤0.01% 5038
2022
Q4
$545K Buy
87,495
+21,729
+33% +$155K ﹤0.01% 5318
2022
Q3
$440K Sell
65,766
-8,826
-12% -$60.6K ﹤0.01% 5505
2022
Q2
$475K Sell
74,592
-13,821
-16% -$78.4K ﹤0.01% 5468
2022
Q1
$410K Sell
88,413
-50,340
-36% -$216K ﹤0.01% 5972
2021
Q4
$694K Buy
138,753
+61,605
+80% +$493K ﹤0.01% 5597
2021
Q3
$929K Buy
77,148
+51,020
+195% +$743K ﹤0.01% 5155
2021
Q2
$553K Sell
26,128
-13,229
-34% -$319K ﹤0.01% 5344
2021
Q1
$1.1M Buy
39,357
+2,091
+6% +$61.7K ﹤0.01% 4742
2020
Q4
$969K Sell
37,266
-1,983
-5% -$59.4K ﹤0.01% 4531
2020
Q3
$1.46M Buy
39,249
+4,491
+13% +$178K ﹤0.01% 3910
2020
Q2
$1.78M Buy
34,758
+11,197
+48% +$468K ﹤0.01% 3717
2020
Q1
$744K Buy
23,561
+418
+2% +$22.1K ﹤0.01% 4205
2019
Q4
$1.38M Buy
23,143
+815
+4% +$36.6K ﹤0.01% 4278
2019
Q3
$818K Sell
22,328
-45,396
-67% -$1.8M ﹤0.01% 4697
2019
Q2
$3.15M Sell
67,724
-6,545
-9% -$307K ﹤0.01% 3653
2019
Q1
$2.98M Buy
74,269
+44,591
+150% +$2M ﹤0.01% 3653
2018
Q4
$1.36M Buy
29,678
+15,943
+116% +$768K ﹤0.01% 4162
2018
Q3
$608K Sell
13,735
-70,437
-84% -$3.23M ﹤0.01% 4815
2018
Q2
$3.3M Buy
84,172
+36,297
+76% +$1.83M ﹤0.01% 3552
2018
Q1
$3.46M Buy
47,875
+4,948
+12% +$363K ﹤0.01% 3422
2017
Q4
$2.83M Buy
42,927
+8,146
+23% +$439K ﹤0.01% 3653
2017
Q3
$1.74M Buy
34,781
+2,998
+9% +$145K ﹤0.01% 4093
2017
Q2
$1.47M Buy
31,783
+11,298
+55% +$415K ﹤0.01% 4148
2017
Q1
$723K Sell
20,485
-90,038
-81% -$2.06M ﹤0.01% 4642
2016
Q4
$1.38M Buy
110,523
+3,152
+3% +$37.5K ﹤0.01% 4077
2016
Q3
$1.49M Sell
107,371
-1,010
-0.9% -$11.4K ﹤0.01% 3879
2016
Q2
$1.07M Buy
108,381
+3,694
+4% +$61.2K ﹤0.01% 4123
2016
Q1
$1.77M Sell
104,687
-20,882
-17% -$336K ﹤0.01% 3668
2015
Q4
$2.79M Sell
125,569
-22,295
-15% -$562K ﹤0.01% 3501
2015
Q3
$3.49M Sell
147,864
-26,932
-15% -$1.69M ﹤0.01% 3233
2015
Q2
$14.3M Buy
174,796
+134,364
+332% +$13.2M 0.01% 1659
2015
Q1
$3.74M Buy
40,432
+38,366
+1,857% +$2.48M ﹤0.01% 2715
2014
Q4
$84K Buy
2,066
+1,779
+620% +$54.5K ﹤0.01% 6005
2014
Q3
$7K Sell
287
-617
-68% -$9.8K ﹤0.01% 7446
2014
Q2
$14K Buy
904
+345
+62% +$4.99K ﹤0.01% 7326
2014
Q1
$8K Sell
559
-2,479
-82% -$38.5K ﹤0.01% 7243
2013
Q4
$42K Buy
3,038
+2,488
+452% +$36.2K ﹤0.01% 6664
2013
Q3
$10K Buy
+550
New +$9.24K ﹤0.01% 7167

Other funds holding ESPR